Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vivo Bio Tech's Enterprise Value is ₹1,183.6 Mil.
Vivo Bio Tech's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹106.6 Mil. Therefore, Vivo Bio Tech's EV-to-EBIT ratio for today is 11.10.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Vivo Bio Tech's Enterprise Value is ₹1,183.6 Mil.
Vivo Bio Tech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹212.9 Mil. Therefore, Vivo Bio Tech's EV-to-EBITDA ratio for today is 5.56.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Vivo Bio Tech's Enterprise Value is ₹1,183.6 Mil.
Vivo Bio Tech's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹533.3 Mil. Therefore, Vivo Bio Tech's EV-to-Revenue ratio for today is 2.22.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Vivo Bio Tech's Enterprise Value is ₹1,183.6 Mil.
Vivo Bio Tech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil. Therefore, Vivo Bio Tech's EV-to-FCF ratio for today is .
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Vivo Bio Tech (BOM:511509) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Vivo Bio Tech's current Enterprise Value is ₹1,183.6 Mil.
Vivo Bio Tech's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹106.6 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Vivo Bio Tech's current Enterprise Value is ₹1,183.6 Mil.
Vivo Bio Tech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹212.9 Mil.
Vivo Bio Tech's current Enterprise Value is ₹1,183.6 Mil.
Vivo Bio Tech's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹533.3 Mil.
Vivo Bio Tech's current Enterprise Value is ₹1,183.6 Mil.
Vivo Bio Tech's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.
Vivo Bio Tech's current Enterprise Value is ₹1,183.6 Mil.
Vivo Bio Tech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivo Bio Tech Enterprise Value Related Terms
Vivo Bio Tech Enterprise Value Historical Data
* Premium members only.
The historical data trend for Vivo Bio Tech's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:511509 vs VRTX, REGN, ALNY: Enterprise Value Comparison
For the Biotechnology subindustry, Vivo Bio Tech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vivo Bio Tech Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vivo Bio Tech's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Vivo Bio Tech's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Vivo Bio Tech's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of ₹1,183.6 Mil mean?
Vivo Bio Tech (BOM:511509) has a Enterprise Value of ₹1,183.6 Mil as of Jul. 05, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Vivo Bio Tech and its competitors.
Is Vivo Bio Tech's Enterprise Value too high?
Vivo Bio Tech's current Enterprise Value is ₹1,183.6 Mil. Overall, Vivo Bio Tech has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vivo Bio Tech's Enterprise Value compare to VRTX and REGN?
Vivo Bio Tech's Enterprise Value of ₹1,183.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Vivo Bio Tech and its competitors. Vivo Bio Tech's current Enterprise Value is ₹1,183.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivo Bio Tech stock overvalued right now?
Based on GuruFocus' analysis, Vivo Bio Tech (BOM:511509) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹29.49, compared to a current price of ₹23.62 — trading 19.9% below its estimated fair value. The current Enterprise Value is ₹1,183.6 Mil. Vivo Bio Tech's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Vivo Bio Tech (BOM:511509), the current Enterprise Value is ₹1,183.6 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vivo Bio Tech (BOM:511509) Overvalued in 2026?
Based on GuruFocus' analysis, Vivo Bio Tech stock appears to be undervalued.
The current stock price of ₹23.62 is trading 19.9% below its estimated GF Value™ of ₹29.49.
GuruFocus considers Vivo Bio Tech to be Modestly Undervalued.
Key valuation signals for BOM:511509:
Enterprise Value: ₹1,183.6 Mil
GF Value™: ₹29.49 vs. price of ₹23.62 (19.9% below fair value)
No single metric tells the full story. See the BOM:511509 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
69GF Score
Get the complete analysis for BOM:511509
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:511509 has been successfully added to your 
